Tandem Diabetes (TNDM) Misses Q3 EPS, Revenue; Guides Lower

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. CVS
9. SPY
10. XYZ

Go back to Tandem Diabetes (TNDM) Misses Q3 EPS, Revenue; Guides Lower

Tandem Diabetes Care Announces Third Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

November 2, 2022 4:05 PM EDT

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2022 and updated its financial guidance for the year ending December 31, 2022.

Third Quarter 2022 Financial Highlights Compared to Third Quarter 2021:

Worldwide installed base increased 35 percent to more than 400,000 customers. Worldwide sales increased 14 percent to $204.5 million. Renewal pump shipments in the United States increased nearly 70 percent. Sales outside the United States increased 26 percent to $58.5 million. $608.7 million in... More